Forte Biosciences
(NASDAQ) FBRX
Forte Biosciences Financials at a Glance
Market Cap
$434.34M
Revenue (TTM)
$0.00
Net Income (TTM)
$69.38M
EPS (TTM)
$-5.24
P/E Ratio
-5.97
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$31.33
Volume
8,030
Open
$30.84
Price
$31.33
Volume
8,030
Open
$30.84
Previous Close
$31.33
Daily Range
$29.84 - $31.39
52-Week Range
$4.90 - $35.80
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$31.33
Volume
8,030
Open
$30.84
Previous Close
$31.33
Daily Range
$29.84 - $31.39
52-Week Range
$4.90 - $35.80
FBRX News
FBRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Forte Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
19
CEO
Paul A. Wagner, PhD, CFA
Website
www.fortebiorx.comHeadquarters
Dallas, TX 75247, US
FBRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-122%
Return on Capital
-1%
Return on Assets
-84%
Earnings Yield
-16.75%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$434.34M
Shares Outstanding
13.89M
Volume
8.03K
Short Interest
0.00%
Avg. Volume
285.34K
Financials (TTM)
Gross Profit
$64.00K
Operating Income
$70.66M
EBITDA
$70.59M
Operating Cash Flow
$50.88M
Capital Expenditure
$116.00K
Free Cash Flow
$51.00M
Cash & ST Invst.
$76.96M
Total Debt
$0.00
Forte Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$45.00K
+550.0%
Gross Margin
0.00%
N/A
Market Cap
$434.34M
N/A
Market Cap/Employee
$31.02M
N/A
Employees
14
N/A
Net Income
$24.79M
-246.4%
EBITDA
$24.55M
-243.6%
Quarterly Fundamentals
Net Cash
$76.96M
+31.9%
Accounts Receivable
$817.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-83.81%
N/A
Return on Invested Capital
-1.14%
N/A
Free Cash Flow
$16.47M
-64.0%
Operating Cash Flow
$16.47M
-64.5%